PI3Kγ is a molecular switch that controls immune suppression.

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Macrophages exhibit dual roles in inflammation and cancer, promoting either immune stimulation or suppression.
• Macrophage polarization is crucial for regulating immune responses in various diseases.

Purpose of the Study:

• To investigate the role of macrophage phosphoinositide 3-kinase gamma (PI3Kγ) in controlling immune responses.
• To determine if PI3Kγ signaling regulates the switch between immune-stimulating and immune-suppressing macrophage phenotypes.
• To evaluate PI3Kγ as a therapeutic target in cancer.

Main Methods:

• Utilized genetic manipulation to selectively inactivate macrophage PI3Kγ in mouse models.
• Analyzed downstream signaling pathways including Akt, mTOR, NFκB, and C/EBPβ.
• Assessed T cell activation, cytotoxicity, and tumor regression in response to PI3Kγ modulation and checkpoint inhibitor therapy.

Main Results:

• Macrophage PI3Kγ signaling promotes immune suppression by inhibiting NFκB and activating C/EBPβ.
• Selective PI3Kγ inactivation in macrophages enhances NFκB activation and promotes an immunostimulatory phenotype.
• PI3Kγ inhibition synergizes with checkpoint inhibitors to induce tumor regression and improve survival in mouse cancer models.
• PI3Kγ-regulated gene expression predicts patient survival.

Conclusions:

• Macrophage PI3Kγ is a critical regulator of the immune response in inflammation and cancer.
• Targeting PI3Kγ can reprogram macrophages towards an immunostimulatory state, enhancing anti-tumor immunity.
• PI3Kγ inhibition represents a promising therapeutic strategy, particularly in combination with checkpoint inhibitors, for cancer treatment.